1 Leiomyosarcoma Drug Market Overview 1.1 Leiomyosarcoma Drug Product Overview 1.2 Leiomyosarcoma Drug Market Segment by Type 1.2.1 AL-3818 1.2.2 BGB-290 1.2.3 C-21 1.2.4 Others 1.3 Global Leiomyosarcoma Drug Market Size by Type 1.3.1 Global Leiomyosarcoma Drug Market Size Overview by Type (2016-2027) 1.3.2 Global Leiomyosarcoma Drug Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Leiomyosarcoma Drug Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Leiomyosarcoma Drug Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Leiomyosarcoma Drug Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Leiomyosarcoma Drug Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Leiomyosarcoma Drug Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Leiomyosarcoma Drug Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Leiomyosarcoma Drug Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Leiomyosarcoma Drug Sales Breakdown by Type (2016-2021) 1.4.2 Europe Leiomyosarcoma Drug Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Leiomyosarcoma Drug Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Leiomyosarcoma Drug Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Leiomyosarcoma Drug Sales Breakdown by Type (2016-2021) 2 Global Leiomyosarcoma Drug Market Competition by Company 2.1 Global Top Players by Leiomyosarcoma Drug Sales (2016-2021) 2.2 Global Top Players by Leiomyosarcoma Drug Revenue (2016-2021) 2.3 Global Top Players Leiomyosarcoma Drug Price (2016-2021) 2.4 Global Top Manufacturers Leiomyosarcoma Drug Manufacturing Base Distribution, Sales Area, Product Type 2.5 Leiomyosarcoma Drug Market Competitive Situation and Trends 2.5.1 Leiomyosarcoma Drug Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Leiomyosarcoma Drug Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Leiomyosarcoma Drug as of 2020) 2.7 Date of Key Manufacturers Enter into Leiomyosarcoma Drug Market 2.8 Key Manufacturers Leiomyosarcoma Drug Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Leiomyosarcoma Drug Status and Outlook by Region 3.1 Global Leiomyosarcoma Drug Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Leiomyosarcoma Drug Historic Market Size by Region 3.2.1 Global Leiomyosarcoma Drug Sales in Volume by Region (2016-2021) 3.2.2 Global Leiomyosarcoma Drug Sales in Value by Region (2016-2021) 3.2.3 Global Leiomyosarcoma Drug Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Leiomyosarcoma Drug Forecasted Market Size by Region 3.3.1 Global Leiomyosarcoma Drug Sales in Volume by Region (2022-2027) 3.3.2 Global Leiomyosarcoma Drug Sales in Value by Region (2022-2027) 3.3.3 Global Leiomyosarcoma Drug Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Leiomyosarcoma Drug by Application 4.1 Leiomyosarcoma Drug Market Segment by Application 4.1.1 Clinic 4.1.2 Hospital 4.1.3 Others 4.2 Global Leiomyosarcoma Drug Market Size by Application 4.2.1 Global Leiomyosarcoma Drug Market Size Overview by Application (2016-2027) 4.2.2 Global Leiomyosarcoma Drug Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Leiomyosarcoma Drug Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Leiomyosarcoma Drug Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Leiomyosarcoma Drug Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Leiomyosarcoma Drug Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Leiomyosarcoma Drug Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Leiomyosarcoma Drug Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Leiomyosarcoma Drug Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Leiomyosarcoma Drug Sales Breakdown by Application (2016-2021) 4.3.2 Europe Leiomyosarcoma Drug Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Leiomyosarcoma Drug Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Leiomyosarcoma Drug Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Leiomyosarcoma Drug Sales Breakdown by Application (2016-2021) 5 North America Leiomyosarcoma Drug by Country 5.1 North America Leiomyosarcoma Drug Historic Market Size by Country 5.1.1 North America Leiomyosarcoma Drug Sales in Volume by Country (2016-2021) 5.1.2 North America Leiomyosarcoma Drug Sales in Value by Country (2016-2021) 5.2 North America Leiomyosarcoma Drug Forecasted Market Size by Country 5.2.1 North America Leiomyosarcoma Drug Sales in Volume by Country (2022-2027) 5.2.2 North America Leiomyosarcoma Drug Sales in Value by Country (2022-2027) 6 Europe Leiomyosarcoma Drug by Country 6.1 Europe Leiomyosarcoma Drug Historic Market Size by Country 6.1.1 Europe Leiomyosarcoma Drug Sales in Volume by Country (2016-2021) 6.1.2 Europe Leiomyosarcoma Drug Sales in Value by Country (2016-2021) 6.2 Europe Leiomyosarcoma Drug Forecasted Market Size by Country 6.2.1 Europe Leiomyosarcoma Drug Sales in Volume by Country (2022-2027) 6.2.2 Europe Leiomyosarcoma Drug Sales in Value by Country (2022-2027) 7 Asia-Pacific Leiomyosarcoma Drug by Region 7.1 Asia-Pacific Leiomyosarcoma Drug Historic Market Size by Region 7.1.1 Asia-Pacific Leiomyosarcoma Drug Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Leiomyosarcoma Drug Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Leiomyosarcoma Drug Forecasted Market Size by Region 7.2.1 Asia-Pacific Leiomyosarcoma Drug Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Leiomyosarcoma Drug Sales in Value by Region (2022-2027) 8 Latin America Leiomyosarcoma Drug by Country 8.1 Latin America Leiomyosarcoma Drug Historic Market Size by Country 8.1.1 Latin America Leiomyosarcoma Drug Sales in Volume by Country (2016-2021) 8.1.2 Latin America Leiomyosarcoma Drug Sales in Value by Country (2016-2021) 8.2 Latin America Leiomyosarcoma Drug Forecasted Market Size by Country 8.2.1 Latin America Leiomyosarcoma Drug Sales in Volume by Country (2022-2027) 8.2.2 Latin America Leiomyosarcoma Drug Sales in Value by Country (2022-2027) 9 Middle East and Africa Leiomyosarcoma Drug by Country 9.1 Middle East and Africa Leiomyosarcoma Drug Historic Market Size by Country 9.1.1 Middle East and Africa Leiomyosarcoma Drug Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Leiomyosarcoma Drug Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Leiomyosarcoma Drug Forecasted Market Size by Country 9.2.1 Middle East and Africa Leiomyosarcoma Drug Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Leiomyosarcoma Drug Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Leiomyosarcoma Drug Business 10.1 Advenchen Laboratories, LLC 10.1.1 Advenchen Laboratories, LLC Corporation Information 10.1.2 Advenchen Laboratories, LLC Introduction and Business Overview 10.1.3 Advenchen Laboratories, LLC Leiomyosarcoma Drug Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Advenchen Laboratories, LLC Leiomyosarcoma Drug Products Offered 10.1.5 Advenchen Laboratories, LLC Recent Development 10.2 BeiGene, Ltd. 10.2.1 BeiGene, Ltd. Corporation Information 10.2.2 BeiGene, Ltd. Introduction and Business Overview 10.2.3 BeiGene, Ltd. Leiomyosarcoma Drug Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Advenchen Laboratories, LLC Leiomyosarcoma Drug Products Offered 10.2.5 BeiGene, Ltd. Recent Development 10.3 Cell Medica Limited 10.3.1 Cell Medica Limited Corporation Information 10.3.2 Cell Medica Limited Introduction and Business Overview 10.3.3 Cell Medica Limited Leiomyosarcoma Drug Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Cell Medica Limited Leiomyosarcoma Drug Products Offered 10.3.5 Cell Medica Limited Recent Development 10.4 Karyopharm Therapeutics, Inc. 10.4.1 Karyopharm Therapeutics, Inc. Corporation Information 10.4.2 Karyopharm Therapeutics, Inc. Introduction and Business Overview 10.4.3 Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Products Offered 10.4.5 Karyopharm Therapeutics, Inc. Recent Development 10.5 Merck & Co., Inc. 10.5.1 Merck & Co., Inc. Corporation Information 10.5.2 Merck & Co., Inc. Introduction and Business Overview 10.5.3 Merck & Co., Inc. Leiomyosarcoma Drug Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Merck & Co., Inc. Leiomyosarcoma Drug Products Offered 10.5.5 Merck & Co., Inc. Recent Development 10.6 Mirati Therapeutics Inc. 10.6.1 Mirati Therapeutics Inc. Corporation Information 10.6.2 Mirati Therapeutics Inc. Introduction and Business Overview 10.6.3 Mirati Therapeutics Inc. Leiomyosarcoma Drug Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Mirati Therapeutics Inc. Leiomyosarcoma Drug Products Offered 10.6.5 Mirati Therapeutics Inc. Recent Development 10.7 Novartis AG 10.7.1 Novartis AG Corporation Information 10.7.2 Novartis AG Introduction and Business Overview 10.7.3 Novartis AG Leiomyosarcoma Drug Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Novartis AG Leiomyosarcoma Drug Products Offered 10.7.5 Novartis AG Recent Development 10.8 Vicore Pharma AB 10.8.1 Vicore Pharma AB Corporation Information 10.8.2 Vicore Pharma AB Introduction and Business Overview 10.8.3 Vicore Pharma AB Leiomyosarcoma Drug Sales, Revenue and Gross Margin (2016-2021) 10.8.4 Vicore Pharma AB Leiomyosarcoma Drug Products Offered 10.8.5 Vicore Pharma AB Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Leiomyosarcoma Drug Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Leiomyosarcoma Drug Industrial Chain Analysis 11.4 Leiomyosarcoma Drug Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Leiomyosarcoma Drug Distributors 12.3 Leiomyosarcoma Drug Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of AL-3818 Table 2. Major Company of BGB-290 Table 3. Major Company of C-21 Table 4. Major Company of Others Table 5. Global Leiomyosarcoma Drug Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Leiomyosarcoma Drug Sales by Type (2016-2021) & (K Pcs) Table 7. Global Leiomyosarcoma Drug Sales Market Share in Volume by Type (2016-2021) Table 8. Global Leiomyosarcoma Drug Sales by Type (2016-2021) & (US& Million) Table 9. Global Leiomyosarcoma Drug Market Share in Value by Type (2016-2021) Table 10. Global Leiomyosarcoma Drug Price by Type (2016-2021) & (USD/Pcs) Table 11. Global Leiomyosarcoma Drug Sales by Type (2022-2027) & (K Pcs) Table 12. Global Leiomyosarcoma Drug Sales Market Share in Volume by Type (2022-2027) Table 13. Global Leiomyosarcoma Drug Sales by Type (2022-2027) & (US$ Million) Table 14. Global Leiomyosarcoma Drug Sales Market Share in Value by Type (2022-2027) Table 15. Global Leiomyosarcoma Drug Price by Type (2022-2027) & (USD/Pcs) Table 16. North America Leiomyosarcoma Drug Sales by Type (2016-2021) & (K Pcs) Table 17. North America Leiomyosarcoma Drug Sales by Type (2016-2021) & (US$ Million) Table 18. Europe Leiomyosarcoma Drug Sales (K Pcs) by Type (2016-2021) Table 19. Europe Leiomyosarcoma Drug Sales by Type (2016-2021) & (US$ Million) Table 20. Asia-Pacific Leiomyosarcoma Drug Sales (K Pcs) by Type (2016-2021) Table 21. Asia-Pacific Leiomyosarcoma Drug Sales by Type (2016-2021) & (US$ Million) Table 22. Latin America Leiomyosarcoma Drug Sales (K Pcs) by Type (2016-2021) Table 23. Latin America Leiomyosarcoma Drug Sales by Type (2016-2021) & (US$ Million) Table 24. Middle East and Africa Leiomyosarcoma Drug Sales (K Pcs) by Type (2016-2021) Table 25. Middle East and Africa Leiomyosarcoma Drug Sales by Type (2016-2021) & (US$ Million) Table 26. Global Leiomyosarcoma Drug Sales by Company (2016-2021) & (K Pcs) Table 27. Global Leiomyosarcoma Drug Sales Share by Company (2016-2021) Table 28. Global Leiomyosarcoma Drug Revenue by Company (2016-2021) & (US$ Million) Table 29. Global Leiomyosarcoma Drug Revenue Share by Company (2016-2021) Table 30. Global Market Leiomyosarcoma Drug Price by Company (2016-2021) & (USD/Pcs) Table 31. Global Leiomyosarcoma Drug Top Manufacturers Manufacturing Base Distribution and Sales Area Table 32. Global Leiomyosarcoma Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Leiomyosarcoma Drug as of 2020 Table 34. Date of Key Manufacturers Enter into Leiomyosarcoma Drug Market Table 35. Key Manufacturers Leiomyosarcoma Drug Product Type Table 36. Mergers & Acquisitions, Expansion Plans Table 37. Global Leiomyosarcoma Drug Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 38. Global Leiomyosarcoma Drug Sales by Region (2016-2021) & (K Pcs) Table 39. Global Leiomyosarcoma Drug Sales Market Share in Volume by Region (2016-2021) Table 40. Global Leiomyosarcoma Drug Sales by Region (2016-2021) & (US$ Million) Table 41. Global Leiomyosarcoma Drug Sales Market Share in Value by Region (2016-2021) Table 42. Global Leiomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 43. Global Leiomyosarcoma Drug Sales by Region (2022-2027) & (K Pcs) Table 44. Global Leiomyosarcoma Drug Sales Market Share in Volume by Region (2022-2027) Table 45. Global Leiomyosarcoma Drug Sales by Region (2022-2027) & (US$ Million) Table 46. Global Leiomyosarcoma Drug Sales Market Share in Value by Region (2022-2027) Table 47. Global Leiomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027) Table 48. Global Leiomyosarcoma Drug Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 49. Global Leiomyosarcoma Drug Sales by Application (2016-2021) & (K Pcs) Table 50. Global Leiomyosarcoma Drug Sales Market Share in Volume by Application (2016-2021) Table 51. Global Leiomyosarcoma Drug Sales by Application (2016-2021) & (US$ Million) Table 52. Global Leiomyosarcoma Drug Sales Market Share in Value by Application (2016-2021) Table 53. Global Leiomyosarcoma Drug Price by Application (2016-2021) & (USD/Pcs) Table 54. Global Leiomyosarcoma Drug Sales by Application (2022-2027) & (K Pcs) Table 55. Global Leiomyosarcoma Drug Sales Market Share in Volume by Application (2022-2027) Table 56. Global Leiomyosarcoma Drug Sales by Application (2022-2027) & (US$ Million) Table 57. Global Leiomyosarcoma Drug Sales Market Share in Value by Application (2022-2027) Table 58. Global Leiomyosarcoma Drug Price by Application (2022-2027) & (USD/Pcs) Table 59. North America Leiomyosarcoma Drug Sales by Application (2016-2021) (K Pcs) Table 60. North America Leiomyosarcoma Drug Sales by Application (2016-2021) & (US$ Million) Table 61. North America Leiomyosarcoma Drug Sales Market Share in Value by Application in 2020 Table 62. Europe Leiomyosarcoma Drug Sales by Application (2016-2021) (K Pcs) Table 63. Europe Leiomyosarcoma Drug Sales by Application (2016-2021) & (US$ Million) Table 64. Europe Leiomyosarcoma Drug Sales Market Share in Value by Application in 2020 Table 65. Asia-Pacific Leiomyosarcoma Drug Sales by Application (2016-2021) (K Pcs) Table 66. Asia-Pacific Leiomyosarcoma Drug Sales by Application (2016-2021) & (US$ Million) Table 67. Asia-Pacific Leiomyosarcoma Drug Sales Market Share in Value by Application in 2020 Table 68. Latin America Leiomyosarcoma Drug Sales by Application (2016-2021) (K Pcs) Table 69. Latin America Leiomyosarcoma Drug Sales by Application (2016-2021) & (US$ Million) Table 70. Latin America Leiomyosarcoma Drug Sales Market Share in Value by Application in 2020 Table 71. Middle East and Africa Leiomyosarcoma Drug Sales by Application (2016-2021) (K Pcs) Table 72. Middle East and Africa Leiomyosarcoma Drug Sales by Application (2016-2021) & (US$ Million) Table 73. Middle East and Africa Leiomyosarcoma Drug Sales Market Share in Value by Application in 2020 Table 74. North America Leiomyosarcoma Drug Sales by Country (2016-2021) & (K Pcs) Table 75. North America Leiomyosarcoma Drug Sales Market Share in Volume by Country (2016-2021) Table 76. North America Leiomyosarcoma Drug Sales by Country (2016-2021) & (US$ Million) Table 77. North America Leiomyosarcoma Drug Sales Market Share in Value by Country (2016-2021) Table 78. North America Leiomyosarcoma Drug Sales by Country (2022-2027) & (K Pcs) Table 79. North America Leiomyosarcoma Drug Sales Market Share in Volume by Country (2022-2027) Table 80. North America Leiomyosarcoma Drug Sales by Country (2022-2027) & (US$ Million) Table 81. North America Leiomyosarcoma Drug Sales Market Share in Value by Country (2022-2027) Table 82. Europe Leiomyosarcoma Drug Sales by Country (2016-2021) & (K Pcs) Table 83. Europe Leiomyosarcoma Drug Sales Market Share in Volume by Country (2016-2021) Table 84. Europe Leiomyosarcoma Drug Sales by Country (2016-2021) & (US$ Million) Table 85. Europe Leiomyosarcoma Drug Sales Market Share in Value by Country (2016-2021) Table 86. Europe Leiomyosarcoma Drug Sales by Country (2022-2027) & (K Pcs) Table 87. Europe Leiomyosarcoma Drug Sales Market Share in Volume by Country (2022-2027) Table 88. Europe Leiomyosarcoma Drug Sales by Country (2022-2027) & (US$ Million) Table 89. Europe Leiomyosarcoma Drug Sales Market Share in Value by Country (2022-2027) Table 90. Asia-Pacific Leiomyosarcoma Drug Sales by Region (2016-2021) & (K Pcs) Table 91. Asia-Pacific Leiomyosarcoma Drug Sales Market Share in Volume by Region (2016-2021) Table 92. Asia-Pacific Leiomyosarcoma Drug Sales by Region (2016-2021) & (US$ Million) Table 93. Asia-Pacific Leiomyosarcoma Drug Sales Market Share in Value by Region (2016-2021) Table 94. Asia-Pacific Leiomyosarcoma Drug Sales by Region (2022-2027) & (K Pcs) Table 95. Asia-Pacific Leiomyosarcoma Drug Sales Market Share in Volume by Region (2022-2027) Table 96. Asia-Pacific Leiomyosarcoma Drug Sales by Region (2022-2027) & (US$ Million) Table 97. Asia-Pacific Leiomyosarcoma Drug Sales Market Share in Value by Region (2022-2027) Table 98. Latin America Leiomyosarcoma Drug Sales by Country (2016-2021) & (K Pcs) Table 99. Latin America Leiomyosarcoma Drug Sales Market Share in Volume by Country (2016-2021) Table 100. Latin America Leiomyosarcoma Drug Sales by Country (2016-2021) & (US$ Million) Table 101. Latin America Leiomyosarcoma Drug Sales Market Share in Value by Country (2016-2021) Table 102. Latin America Leiomyosarcoma Drug Sales by Country (2022-2027) & (K Pcs) Table 103. Latin America Leiomyosarcoma Drug Sales Market Share in Volume by Country (2022-2027) Table 104. Latin America Leiomyosarcoma Drug Sales by Country (2022-2027) & (US$ Million) Table 105. Latin America Leiomyosarcoma Drug Sales Market Share in Value by Country (2022-2027) Table 106. Middle East and Africa Leiomyosarcoma Drug Sales by Country (2016-2021) & (K Pcs) Table 107. Middle East and Africa Leiomyosarcoma Drug Sales Market Share in Volume by Country (2016-2021) Table 108. Middle East and Africa Leiomyosarcoma Drug Sales by Country (2016-2021) & (US$ Million) Table 109. Middle East and Africa Leiomyosarcoma Drug Sales Market Share in Value by Country (2016-2021) Table 110. Middle East and Africa Leiomyosarcoma Drug Sales by Country (2022-2027) & (K Pcs) Table 111. Middle East and Africa Leiomyosarcoma Drug Sales Market Share in Volume by Country (2022-2027) Table 112. Middle East and Africa Leiomyosarcoma Drug Sales by Country (2022-2027) & (US$ Million) Table 113. Middle East and Africa Leiomyosarcoma Drug Sales Market Share in Value by Country (2022-2027) Table 114. Advenchen Laboratories, LLC Corporation Information Table 115. Advenchen Laboratories, LLC Introduction and Business Overview Table 116. Advenchen Laboratories, LLC Leiomyosarcoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 117. Advenchen Laboratories, LLC Leiomyosarcoma Drug Product Table 118. Advenchen Laboratories, LLC Recent Development Table 119. BeiGene, Ltd. Corporation Information Table 120. BeiGene, Ltd. Introduction and Business Overview Table 121. BeiGene, Ltd. Leiomyosarcoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 122. BeiGene, Ltd. Leiomyosarcoma Drug Product Table 123. BeiGene, Ltd. Recent Development Table 124. Cell Medica Limited Corporation Information Table 125. Cell Medica Limited Introduction and Business Overview Table 126. Cell Medica Limited Leiomyosarcoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 127. Cell Medica Limited Leiomyosarcoma Drug Product Table 128. Cell Medica Limited Recent Development Table 129. Karyopharm Therapeutics, Inc. Corporation Information Table 130. Karyopharm Therapeutics, Inc. Introduction and Business Overview Table 131. Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 132. Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Product Table 133. Karyopharm Therapeutics, Inc. Recent Development Table 134. Merck & Co., Inc. Corporation Information Table 135. Merck & Co., Inc. Introduction and Business Overview Table 136. Merck & Co., Inc. Leiomyosarcoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 137. Merck & Co., Inc. Leiomyosarcoma Drug Product Table 138. Merck & Co., Inc. Recent Development Table 139. Mirati Therapeutics Inc. Corporation Information Table 140. Mirati Therapeutics Inc. Introduction and Business Overview Table 141. Mirati Therapeutics Inc. Leiomyosarcoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 142. Mirati Therapeutics Inc. Leiomyosarcoma Drug Product Table 143. Mirati Therapeutics Inc. Recent Development Table 144. Novartis AG Corporation Information Table 145. Novartis AG Introduction and Business Overview Table 146. Novartis AG Leiomyosarcoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 147. Novartis AG Leiomyosarcoma Drug Product Table 148. Novartis AG Recent Development Table 149. Vicore Pharma AB Corporation Information Table 150. Vicore Pharma AB Introduction and Business Overview Table 151. Vicore Pharma AB Leiomyosarcoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 152. Vicore Pharma AB Leiomyosarcoma Drug Product Table 153. Vicore Pharma AB Recent Development Table 154. Key Raw Materials Lists Table 155. Raw Materials Key Suppliers Lists Table 156. Leiomyosarcoma Drug Market Trends Table 157. Leiomyosarcoma Drug Market Drivers Table 158. Leiomyosarcoma Drug Market Challenges Table 159. Leiomyosarcoma Drug Market Restraints Table 160. Leiomyosarcoma Drug Distributors List Table 161. Leiomyosarcoma Drug Downstream Customers Table 162. Research Programs/Design for This Report Table 163. Key Data Information from Secondary Sources Table 164. Key Data Information from Primary Sources List of Figures Figure 1. Leiomyosarcoma Drug Product Picture Figure 2. Global Leiomyosarcoma Drug Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Leiomyosarcoma Drug Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Leiomyosarcoma Drug Sales Status and Outlook (2016-2027) & (K Pcs) Figure 5. Product Picture of AL-3818 Figure 6. Global AL-3818 Sales YoY Growth (2016-2021) & (K Pcs) Figure 7. Product Picture of BGB-290 Figure 8. Global BGB-290 Sales YoY Growth (2016-2021) & (K Pcs) Figure 9. Product Picture of C-21 Figure 10. Global C-21 Sales YoY Growth (2016-2021) & (K Pcs) Figure 11. Product Picture of Others Figure 12. Global Others Sales YoY Growth (2016-2021) & (K Pcs) Figure 13. Global Leiomyosarcoma Drug Sales by Type (2016-2027) & (US$ Million) Figure 14. Global Leiomyosarcoma Drug Sales Market Share in Volume by Type (2016-2021) Figure 15. Global Leiomyosarcoma Drug Sales Market Share in Value by Type (2016-2021) Figure 16. Global Leiomyosarcoma Drug Sales Market Share in Volume by Type (2022-2027) Figure 17. Global Leiomyosarcoma Drug Sales Market Share in Value by Type (2022-2027) Figure 18. North America Leiomyosarcoma Drug Sales Market Share in Volume by Type in 2020 Figure 19. North America Leiomyosarcoma Drug Sales Market Share in Value by Type in 2020 Figure 20. Europe Leiomyosarcoma Drug Sales Market Share in Volume by Type in 2020 Figure 21. Europe Leiomyosarcoma Drug Sales Market Share in Value by Type in 2020 Figure 22. Asia-Pacific Leiomyosarcoma Drug Sales Market Share in Volume by Type in 2020 Figure 23. Asia-Pacific Leiomyosarcoma Drug Sales Market Share in Value by Type in 2020 Figure 24. Latin America Leiomyosarcoma Drug Sales Market Share in Volume by Type in 2020 Figure 25. Latin America Leiomyosarcoma Drug Sales Market Share in Value by Type in 2020 Figure 26. Middle East and Africa Leiomyosarcoma Drug Sales Market Share in Volume by Type in 2020 Figure 27. Middle East and Africa Leiomyosarcoma Drug Sales Market Share in Value by Type in 2020 Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Leiomyosarcoma Drug Sales in 2020 Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Leiomyosarcoma Drug Revenue in 2020 Figure 30. Leiomyosarcoma Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 31. Product Picture of Clinic Figure 32. Global Clinic Sales YoY Growth (2016-2027) & (K Pcs) Figure 33. Product Picture of Hospital Figure 34. Global Hospital Sales YoY Growth (2016-2027) & (K Pcs) Figure 35. Product Picture of Others Figure 36. Global Others Sales YoY Growth (2016-2027) & (K Pcs) Figure 37. Global Leiomyosarcoma Drug Sales by Application (2016-2027) & (US$ Million) Figure 38. Global Leiomyosarcoma Drug Sales Market Share in Volume by Application (2016-2021) Figure 39. Global Leiomyosarcoma Drug Sales Market Share in Value by Application (2016-2021) Figure 40. Global Leiomyosarcoma Drug Sales Market Share in Volume by Application (2022-2027) Figure 41. North America Leiomyosarcoma Drug Sales Market Share in Volume by Application in 2020 Figure 42. Latin America Leiomyosarcoma Drug Sales Market Share in Value by Application in 2020 Figure 43. Middle East and Africa Leiomyosarcoma Drug Sales Market Share in Value by Application in 2020 Figure 44. Key Raw Materials Price Figure 45. Leiomyosarcoma Drug Manufacturing Cost Structure Figure 46. Leiomyosarcoma Drug Industrial Chain Analysis Figure 47. Channels of Distribution Figure 48. Distributors Profiles Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation Figure 51. Key Executives Interviewed

Advenchen Laboratories, LLC BeiGene, Ltd. Cell Medica Limited Karyopharm Therapeutics, Inc. Merck & Co., Inc. Mirati Therapeutics Inc. Novartis AG Vicore Pharma AB